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background:  Low-flow (LF) severe aortic stenosis (AS) is an independent predictor of mortality in patients undergoing aortic valve 
replacement (AVR). We hypothesized that improvement in flow (left ventricular stroke volume index (SVI)) after transcatheter AVR (TAVR) 
would predict better clinical outcomes.
methods:  All TAVR patients in The Placement of Aortic Transcatheter Valves (PARTNER) randomized trial or continued access registry 
with evaluable echoes and baseline LF AS (SVI </= 35 ml/m2) were included. Patients were stratified post-TAVR into tertiles by discharge 
SVI (low Group A, intermediate Group B, high Group C). The primary endpoint was one-year mortality.
results:  Baseline characteristics of 984 patients with LF AS included mean age 84 ± 7 years, 59% male, mean STS score 11.4%. The 
baseline and discharge SVI (ml/m2) by group were: 25.9 ± 5.3 vs. 23.1 ± 3.5 (A), 28.1 ± 4.6 vs. 31.7 ± 2.2 (B), 28.8 ± 4.3 vs. 43.1 ± 7.0 (C). 
All cause mortality was 26.5% (A), 20.1% (B), 19.6% (C) (p=0.04, see figure). Cardiovascular mortality was 11.4% (A), 7.9% (B), 6.0% (C) 
(p=0.04).
Conclusion:  Patients with LF AS undergoing TAVR who improved their SVI on discharge echo had lower cardiovascular and total mortality 
compared to similar LF patients without improvement in SVI.
 
